JUVENTAS THERAPEUTICS INC

Profile

Company Names

JUVENTAS THERAPEUTICS INC

Addresses

3615 SUPERIOR AVENUE, SUITE 4403B, CLEVELAND, OH 44114

3615 SUPERIOR AVENUE SUITE 4403C, CLEVELAND, OH 44114

3615 SUPERIOR AVENUE, SUITE 4403C, CLEVELAND, OH 44114

3615 SUPERIOR AVENUE, SUITE 4403 C, CLEVELAND, OH 44114

10000 CEDAR AVENUE, CLEVELAND, OH 44106

Phone Numbers

216-359-0099
216-273-4000
216-445-6514

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$35,757,614.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-09-22 
$1,311,202.00 
$6,000,000.00 
$4,688,798.00 
Debt 
3
2015-05-04 
$7,386,412.00 
$7,386,412.00 
$0.00 
Equity 
2
2013-10-31 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2008-09-30 
$22,060,000.00 
$22,060,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAHUL 
 
ARAS 
EXECUTIVE OFFICER, DIRECTOR
SIRONRX THERAPEUTICS, INC.   |  JUVENTAS THERAPEUTICS INC   |  BETA CAT PHARMACEUTICALS, INC.
GEORGE 
 
ARIDA 
DIRECTOR
NERITES CORP   |  CELLERATION INC   |  CHROMATIN, INC.   |  JUVENTAS THERAPEUTICS INC   |  NANOBIO CORP   |  BLUEWILLOW BIOLOGICS, INC.   |  30VENTURES FUND I, L.P.   |  POPS! DIABETES CARE, INC.
JAMES 
 
BOLAND 
DIRECTOR
TRADE STREET RESIDENTIAL, INC.   |  JUVENTAS THERAPEUTICS INC
SUZETTE 
 
DUTCH 
DIRECTOR
BIOVEX GROUP, INC.   |  TOLERA THERAPEUTICS INC   |  JUVENTAS THERAPEUTICS INC
GEORGE 
 
EMONT 
DIRECTOR
PRADAMA INC   |  RHINOCYTE INC   |  ORTHODATA INC   |  CELLERATION INC   |  APOVAX, INC.   |  SIRONRX THERAPEUTICS, INC.   |  JUVENTAS THERAPEUTICS INC
TROY 
 
IGNELZI 
EXECUTIVE OFFICER
JUVENTAS THERAPEUTICS INC   |  SCPHARMACEUTICALS INC.   |  VEDANTA BIOSCIENCES, INC.
JACK 
 
MINER 
DIRECTOR
JUVENTAS THERAPEUTICS INC   |  JTMSSP LLC
ROGER 
 
NEWTON 
DIRECTOR
JUVENTAS THERAPEUTICS INC   |  FIRST SENSE MEDICAL, LLC   |  DENOVO SCIENCES, INC.   |  CELSEE DIAGNOSTICS, INC.   |  LIFE BOOST INC.   |  CELSEE, INC.
MARC 
 
PENN 
DIRECTOR, EXECUTIVE OFFICER
JUVENTAS THERAPEUTICS INC   |  DIASOME PHARMACEUTICALS, INC.   |  KEYSTONE BIO, INC.   |  INOMAGEN THERAPEUTICS, INC.   |  FOMENT BIO, INC.
MATT 
 
POLLMAN 
DIRECTOR
JUVENTAS THERAPEUTICS INC
MATTHEW 
 
POLLMAN 
EXECUTIVE OFFICER, DIRECTOR
JUVENTAS THERAPEUTICS INC   |  VALCOR CATH INC.
SOMU 
 
SUBRAMANIAM 
DIRECTOR
BIOVEX GROUP, INC.   |  ACHRONIX SEMICONDUCTOR CORP   |  RF ARRAYS INC   |  LIGHTWIRE INC   |  RESOLVE THERAPEUTICS LLC   |  DALI SYSTEMS CO. LTD.   |  TRELLIS BIOSCIENCE LLC   |  BIOSCALE INC   |  SILICON SPACE TECHNOLOGY CORP   |  JUVENTAS THERAPEUTICS INC   |  DIRECTED SENSING INC.   |  PRIVATE GROUP NETWORKS, INC.   |  PERCEPTIMED, INC.   |  SVELTE MEDICAL SYSTEMS INC   |  ALEXAR THERAPEUTICS, INC.   |  NEW SCIENCE VENTURES FUND III, L.P.   |  NEW SCIENCE VENTURES FUND III (OFFSHORE), L.P.   |  VASCULAR THERAPIES INC   |  NSV 2016 OPPORTUNITIES FUND, L.P.   |  NSV 2016 OPPORTUNITIES FUND (OFFSHORE), L.P.   |  NSV 2017 OPPORTUNITIES FUND, L.P.   |  RALEXAR THERAPEUTICS, INC.   |  NSV 2018 NEW HORIZONS FUND, L.P.   |  NSV 2018 OPPORTUNITIES FUND, L.P.   |  NSV 2020 PREFERRED LP FUND, L.P.   |  NSV GROWTH OPPORTUNITIES FUND, L.P.   |  NSV 2021 GROWTH OPPORTUNITIES FUND, L.P.   |  PHASE FOUR, INC.   |  PAKAL TECHNOLOGIES, INC.   |  BRIGHTVOLT, INC   |  ABL SPACE SYSTEMS CO   |  GLYDWAYS, INC.   |  FERRIC, INC.
LINDA 
 
TUFTS 
DIRECTOR
SIRONRX THERAPEUTICS, INC.   |  JUVENTAS THERAPEUTICS INC   |  HISTOSONICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  SWIFT BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-10-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-09-22 
2015-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-04 
2013-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-31 
2012-08-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-09-30 
2012-02-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#